Cargando…

PET-Derived Increased Inflammation in Large Vessels is linked to Relapse-Free Survival in Patients with Giant Cell Arteritis

Background Despite anti-inflammatory treatment, patients with giant cell arteritis (GCA) experience relapse. We aimed to determine respective relapse predictors focusing on [ (18) F]fluorodeoxyglucose ([ (18) F]FDG)-PET-based parameters. Material and Methods 21 therapy-naïve GCA patients received...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fröhlich, Matthias, Schmalzing, Marc, Buck, Andreas, Bley, Thorsten A., Guggenberger, Konstanze V., Werner, Rudolf A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Georg Thieme Verlag KG 2023
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10477020/ https://www.ncbi.nlm.nih.gov/pubmed/37666267 http://dx.doi.org/10.1055/a-2053-7191

Ejemplares similares

Intraorbital findings in giant cell arteritis on black blood MRI
por: Guggenberger, Konstanze V., et al.
Publicado: (2022)

Whole-Body [(18)F]FDG PET/CT Can Alter Diagnosis in Patients with Suspected Rheumatic Disease
por: Fröhlich, Matthias, et al.
Publicado: (2021)

Large-vessel involvement is predictive of multiple relapses in giant cell arteritis
por: de Mornac, Donatienne, et al.
Publicado: (2021)

High-Resolution Black Blood Vessel Wall Imaging in COVID-19 Encephalopathy—Is it Really Endotheliitis?
por: Guggenberger, Konstanze V., et al.
Publicado: (2021)

Imaging in Vasculitis
por: Guggenberger, Konstanze Viktoria, et al.
Publicado: (2020)

Mimickers of Large Vessel Giant Cell Arteritis
por: Ramon, André, et al.
Publicado: (2022)

Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis
por: Karabayas, Maira, et al.
Publicado: (2020)

Vasa vasorum of proximal cerebral arteries after dural crossing — potential imaging confounder in diagnosing intracranial vasculitis in elderly subjects on black-blood MRI
por: Guggenberger, Konstanze Viktoria, et al.
Publicado: (2021)

PET/CT uncovers cranial giant cell arteritis
por: Anati, Tamer, et al.
Publicado: (2021)

Comment on: Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis
por: Mazumder, Rifat, et al.
Publicado: (2021)

Giant cell arteritis with polymyalgia rheumatica on FDG‐PET/CT
por: Baba, Akira, et al.
Publicado: (2017)

Tocilizumab for relapsing and remitting giant cell arteritis: a case series
por: Saha, Pratyasha, et al.
Publicado: (2022)

Mycophenolate mofetil in giant cell arteritis
por: Pankow, Anne, et al.
Publicado: (2023)

Comment on: Evaluation of adjunctive mycophenolate for large vessel giant cell arteritis. Reply
por: Karabayas, Maira
Publicado: (2021)

Takayasu arteritis: clinical importance of extra-vessel uptake on FDG PET/CT
por: Tsuchiya, Junichi, et al.
Publicado: (2019)

Long-term efficacy and safety of tocilizumab in giant cell arteritis and large vessel vasculitis
por: Evans, Jobie, et al.
Publicado: (2016)

Ultrasound halo count in the differential diagnosis of atherosclerosis and large vessel giant cell arteritis
por: Monjo-Henry, Irene, et al.
Publicado: (2023)

Giant Cell Arteritis
por: Coulier, Bruno, et al.
Publicado: (2018)

Giant Cell Arteritis versus Takayasu Arteritis: An Update
por: Stamatis, Pavlos
Publicado: (2020)

Effect of Glucocorticoid Treatment on Computed Tomography Angiography Detected Large-Vessel Inflammation in Giant-Cell Arteritis. A Prospective, Longitudinal Study
por: Prieto-González, Sergio, et al.
Publicado: (2015)

Covid-19-vaccine-pfizer-biontech: Large-vessel giant cell arteritis: case report
Publicado: (2022)

Cardiovascular Magnetic Resonance Detects Myocardial Inflammation in Giant Cell Arteritis
por: Mavrogeni, Sophie I., et al.
Publicado: (2021)

Aging-Related Vascular Inflammation: Giant Cell Arteritis and Neurological Disorders
por: Watanabe, Ryu, et al.
Publicado: (2022)

Different Scoring Methods of FDG PET/CT in Giant Cell Arteritis: Need for Standardization
por: Stellingwerff, Menno D., et al.
Publicado: (2015)

Positron Emission Tomography (PET) Scan as a Diagnostic Tool for Giant Cell Arteritis
por: Ramachandran, Akshaya, et al.
Publicado: (2023)

Treatment of Giant Cell Arteritis and Takayasu Arteritis—Current and Future
por: Hellmich, B., et al.
Publicado: (2020)

Specific microbiome profile in Takayasu’s arteritis and giant cell arteritis
por: Desbois, Anne Claire, et al.
Publicado: (2021)

Does the halo count on temporal and axillary ultrasound predict time to relapse in giant cell arteritis?
por: Esperança Almeida, Diogo, et al.
Publicado: (2023)

Large-Vessel Giant Cell Arteritis following COVID-19—What Can HLA Typing Reveal?
por: Stojanovic, Maja, et al.
Publicado: (2023)

ROS-producing immature neutrophils in giant cell arteritis are linked to vascular pathologies
por: Wang, Lihui, et al.
Publicado: (2020)

Successful use of ixekizumab for glucocorticoid-free remission maintenance in giant cell arteritis
por: Tomelleri, Alessandro, et al.
Publicado: (2022)

FDG-PET of Takayasu’s Arteritis
por: Shikino, Kiyoshi, et al.
Publicado: (2014)

Performance of Deauville Criteria in ([18F])FDG-PET/CT Diagnostics of Giant Cell Arteritis
por: Siefert, Jeffrey, et al.
Publicado: (2023)

Patient-reported outcomes provide evidence for increased depressive symptoms and increased mental impairment in giant cell arteritis
por: Froehlich, Matthias, et al.
Publicado: (2023)

Associated factors of poor treatment outcomes in patients with giant cell arteritis: clinical implication of large vessel lesions
por: Sugihara, Takahiko, et al.
Publicado: (2020)

Doppler ultrasound and giant cell arteritis
por: Suelves, Ana Marina, et al.
Publicado: (2010)

An Unusual Presentation of Giant Cell Arteritis
por: Prabhavalkar, Siddhesh, et al.
Publicado: (2012)

Biologic Therapies for Giant Cell Arteritis
por: Harrington, Robert, et al.
Publicado: (2021)

Giant Cell Arteritis and Cardiac Comorbidity
por: Arias, Magela, et al.
Publicado: (2021)

Treatment failure in giant cell arteritis
por: Unizony, Sebastian H, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pvuihiplh70484qndt00b3hvdb